Dear Sir/Madam, Please find the attached intimation of closure of trading window. Thanks and Regards.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Prism Medico and Pharmacy has informed the stock exchanges that its insider trading window is closed from October 1, 2025. The window will reopen 48 hours after the company declares its financial results for the quarter and half year ended September 30, 2025. This is a standard compliance filing under SEBI insider trading regulations to prevent insiders from trading while in possession of unpublished financial results. The intimation was signed by Director Davender Singh and addressed to both BSE and Metropolitan Stock Exchange.
This is a routine regulatory disclosure with no direct impact on the stock price. However, it signals that Q2 and H1 FY26 financial results are imminent, which investors should watch for as the next key catalyst for the stock.